Skip to content

Use of an Occlusal Support Device During the Second Stage of Labor

Use of an Occlusal Support Device During the Second Stage of Labor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02807493
Enrollment
347
Registered
2016-06-21
Start date
2017-04-01
Completion date
2021-03-26
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Pregnancy, Labor and Delivery, Occlusal Support Device

Brief summary

The primary objectives of this study are to determine if the use of an Occlusal Support Device (OSD)(Mouthguard) can reduce the duration and intensity of the second stage of labor, reduce the incidence of labor complications including Caesarian Sections and improve Apgar scores in newborns

Detailed description

Prolonged labor, especially during the second stage of active expulsive effort (the pushing phase), is associated with increased risk of maternal complications (e.g. tissue trauma, postpartum hemorrhage, intra-amniotic infection). Developing an effective method to assist and maximize maternal expulsion effort should be of great value in reducing the number of complications, also including cesarean section or instrumental deliveries. Past studies published in the dental literature have shown that specially designed oral appliances that support the dental occlusion may increase the isometric strength of different muscle groups. Increased strength of the neck muscles could improve efficiency of the Valsalva maneuver in increasing intra-uterine pressure, and thus decreasing the duration of phase II of labor. Nulliparous women with uncomplicated singleton pregnancy will be randomly assigned to either the study group (Dental appliance) or the no dental appliance group. Duration of labor will be measured for both phase I and phase II. Rates for cesarean section and instrument deliveries and other complications will be charted as well as Apgar scores .

Interventions

DEVICEOcclusal Support Device

Bite plate

OTHERControl

Control group

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Nulliparous women * Uncomplicated pregnancy * Singleton pregnancy

Exclusion criteria

* Unable to provide informed consent or comply with study protocol, * High risk and/or complicated pregnancy, * Have multiple fetuses as diagnosed by ultrasound, * Have extensive decay or multiple broken/missing teeth that will interfere with the fabrication of an OSD

Design outcomes

Primary

MeasureTime frameDescription
Stage 2 Duration of LaborDuration of laborDetermine if an Occlusal Support Device (OSD) can reduce the duration of the second stage of labor
Number of Participants With a Cesarian SectionBaselineDetermine if an OSD can reduce the incidence of labor complications including Caesarian Sections
Average Apgar Scoreat minute 1 and minute 5Determine if the use of an OSD can improve Apgar scores in newborns. The Apgar test is done by a doctor, midwife, or nurse. The provider examines the baby's: Breathing effort Heart rate Muscle tone Reflexes Skin color Each category is scored with 0, 1, or 2, depending on the observed condition. Higher scores are better. Scores are added for a total ranging from 0-10.

Countries

United States

Participant flow

Participants by arm

ArmCount
Occlusal Support Device
Support device for women in labor Occlusal Support Device: Bite plate
174
Control
No device given for women in labor Control: Control group
173
Total347

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event52
Overall StudyC-Section Prior to Stage 2 of Labor3139
Overall StudyLost to Follow-up60
Overall StudyOther withdrawal170
Overall StudyPhysician Decision41
Overall StudyProtocol Violation70
Overall StudyWithdrawal by Subject1710

Baseline characteristics

CharacteristicOcclusal Support DeviceControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
174 Participants173 Participants347 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
17 Participants19 Participants36 Participants
Race (NIH/OMB)
Black or African American
11 Participants11 Participants22 Participants
Race (NIH/OMB)
More than one race
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants16 Participants25 Participants
Race (NIH/OMB)
White
134 Participants126 Participants260 Participants
Sex: Female, Male
Female
174 Participants173 Participants347 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1740 / 173
other
Total, other adverse events
5 / 1742 / 173
serious
Total, serious adverse events
0 / 1740 / 173

Outcome results

Primary

Average Apgar Score

Determine if the use of an OSD can improve Apgar scores in newborns. The Apgar test is done by a doctor, midwife, or nurse. The provider examines the baby's: Breathing effort Heart rate Muscle tone Reflexes Skin color Each category is scored with 0, 1, or 2, depending on the observed condition. Higher scores are better. Scores are added for a total ranging from 0-10.

Time frame: at minute 1 and minute 5

ArmMeasureGroupValue (MEAN)Dispersion
Occlusal Support DeviceAverage Apgar ScoreAPGAR at min 17.8 score on a scaleStandard Deviation 1.6
Occlusal Support DeviceAverage Apgar ScoreAPGAR at min 58.8 score on a scaleStandard Deviation 0.5
ControlAverage Apgar ScoreAPGAR at min 17.9 score on a scaleStandard Deviation 1.4
ControlAverage Apgar ScoreAPGAR at min 58.8 score on a scaleStandard Deviation 0.7
Primary

Number of Participants With a Cesarian Section

Determine if an OSD can reduce the incidence of labor complications including Caesarian Sections

Time frame: Baseline

ArmMeasureValue (NUMBER)
Occlusal Support DeviceNumber of Participants With a Cesarian Section12 participants
ControlNumber of Participants With a Cesarian Section13 participants
Primary

Stage 2 Duration of Labor

Determine if an Occlusal Support Device (OSD) can reduce the duration of the second stage of labor

Time frame: Duration of labor

ArmMeasureValue (MEAN)Dispersion
Occlusal Support DeviceStage 2 Duration of Labor120.2 minutesStandard Deviation 88.2
ControlStage 2 Duration of Labor107 minutesStandard Deviation 83.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026